22nd Century Group, Inc. XXII has reduced the outstanding principle of its senior secured credit facility from roughly $22.1 million to approximately $14 million as part of an amendment and waiver process with its lenders.
What Happened
The reduction reflects a waiver and repayment of the $7.5 million minimum cash balance required under terms of the original debenture agreements, which was held in an escrow account, the Buffalo-based company said on Wednesday.
22nd Century also assigned an existing promissory note related to the company's previous holdings in Panacea Life Science Holdings as an additional consideration in the debt reduction transaction.
In a non-monetary exchange, the assigned value of the promissory note was allocated as $600,000 to further principal reduction and $2 million in a decrease in the put price associated with the lenders' outstanding warrants, which portion was subsequently canceled.
Why It Matters
Hugh Kinsman, the company's CFO, said the move is expected to result in annual cash interest savings of roughly $500,000.
"The reduction in principal amounts owed under the senior secured credit facility as a result of the amendment and waiver will provide for annual cash interest savings of approximately $0.5 million per year," Kinsman said.
What's Next
The remaining principal loan balance of $14 million and the remaining $500,000 of the put price will be due at maturity in 2026.
After the debt reduction, the company announced the consummation of a public offering with $5.25 million in gross proceeds, which will be used for general operating purposes.
"We continue to actively manage our balance sheet, with a focus on executing our cost reduction initiatives," Kinsman continued.
Did you miss the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Benefit from Michael Berger's sharp analysis, revealing top cannabis stock opportunities and timely updates.
Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now, before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.
XXII Price Action
22nd Century's shares traded 2.4096% higher at $0.51 per share at the time of writing on Wednesday morning.
Related News
- This NASDAQ Hemp And Tobacco Stock Is Trading Lower Post Q2 Earnings Report, Here's Why
- Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Photo: Courtesy of Josh Appel on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.